tiprankstipranks
Ligand Pharma (LGND)
NASDAQ:LGND

Ligand Pharma (LGND) Stock Investors

769 Followers
Based on 735,043 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold LGND
On average, investors allocate 3.55% of their portfolios to LGND
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 735,043 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding LGND

7.2%
Last 7
Days
26.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding LGND, out of 735,043 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

LGND Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
<0.01%
$72.25
Increased
2.41%
$85.29
Increased
2.95%
$61.82
Based on the activity of 13,848 investors who made their portfolios public
The table shows changes in LGND in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

LGND Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Merck & Company
4.12%
-0.21%
-0.35%
332.28B
Healthcare
Bristol-Myers Squibb
3.25%
+0.09%
+1.35%
89.25B
Healthcare
Baidu
4.94%
+3.21%
+12.31%
41.25B
Communication Services
Applied Materials
4.84%
+1.70%
+4.42%
176.22B
Technology
DraftKings
6.16%
-0.28%
+0.45%
38.43B
Consumer Cyclical
Trade Desk
4.76%
+0.53%
+1.63%
46.36B
Technology
Block
4.38%
-0.55%
-1.83%
44.59B
Technology
Raytheon Technologies
4.14%
+0.06%
-1.67%
138.51B
Industrials
Mercadolibre
5.56%
-0.31%
+0.53%
88.68B
Consumer Cyclical
Cisco Systems
4.43%
+0.82%
+1.16%
195.05B
Technology
Based on the activity of 735,043 active portfolios
Open your Smart Portfolio

LGND Investor Analysis

LGND investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
8.6%
of LGND holders
are under 35
Average Segment Performance
Average P/E Ratio23.14
Beta6.02
Dividend Yield6.25%
LGND investors between 35–55

Between 35–55

12.0%
Last 30 days
Holdings Change
39.8%
of LGND holders
are between 35–55
Average Segment Performance
Average P/E Ratio22.00
Beta10.67
Dividend Yield6.42%
LGND investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
51.6%
of LGND holders
are over 55
Average Segment Performance
Average P/E Ratio21.70
Beta3.83
Dividend Yield7.17%
Overview of age group and performance of LGND stock investors
See who invests in LGND according to age group and performance.

FAQ

How many retail Investors hold LGND?
<0.1% of TipRanks' retail investors hold LGND in their portfolios.
    What is LGND Investor Sentiment?
    LGND’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of LGND in the last 7 days?
      ▲ 7.2% of TipRanks' retail investors changed their holding of LGND in the last 7 days.
        What percentage of retail investors changed their holding of LGND in the last 30 days?
        ▲ 26.3% of TipRanks' retail investors changed their holding of LGND in the last 30 days.
          What is the average age of retail investors who hold LGND?
          The average age of LGND Holders is over 55.
            What other stocks have LGND investors also bought?
            LGND Investors also bought MRK, BMY, BIDU, AMAT, DKNG, TTD, SQ, RTX, MELI, CSCO.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALNYAlnylam Pharma
              BAXBaxter International
              BDXBecton Dickinson
              BCRXBioCryst
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis